Analysis of the relationship between Amyloid β protein and cholesterol in Alzheimer's disease.
Analysis of the relationship between Amyloid β protein and cholesterol in Alzheimer's disease.
批准号:
15590891
负责人:
URAKAMI Katsuya
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
阿尔茨海默病(AD)是老年人最常见的神经退行性疾病之一。家族性阿尔茨海默病已知是由β淀粉样蛋白前体(APP)、早老素1或2的突变引起的,尽管这些原因相对不常见。但这些遗传风险因素在所有阿尔茨海默病病因中所占比例不到2%,其余都是散发性阿尔茨海默病。β淀粉样蛋白(Aβ)是阿尔茨海默病大脑中异常积累的蛋白质之一。长期以来,人们一直认为Aβ纤维的形成和沉积与AD的神经发病机制有关。APP的异常加工和a β的升高可能在遗传性和散发性AD的发病机制中起主要作用。我们研究了APP、a β和胆固醇之间的关系,以寻找胆固醇可能在APP的分裂中发挥作用的证据。我们通过转染野生型、瑞典型和鸟取型(D678N)突变的APP,制备了APP过表达的CHO细胞和npc1缺陷的CHO (nCHO)细胞。npc1在尼曼-皮克病C型中存在缺陷,缺乏细胞内转运和维持胆固醇的稳态。我们分析了细胞内胆固醇的数量、合成和酯化,但过量的APP没有直接影响。然后,我们用铝、低密度脂蛋白和氧化应激两种细胞外刺激来测定不同细胞内胆固醇背景下细胞内APP水平和Aβ产量。APP、Aβ与铝没有关系,但nCHO细胞对铝的敏感性高于正常细胞。过量LDL暴露诱导nCHO细胞β-分泌酶裂解APP,提示产生Aβ。CHO细胞氧化应激时细胞内APP水平降低,而nCHO细胞不受影响。膜nCHO中脂质较少,可防止细胞膜受到氧化攻击。胆固醇稳态的破坏可能会加速和增加AD的风险。
英文摘要
Alzheimer's disease (AD) is one of the most frequent neurodegenerative disorders in elder people. Familial AD is known to be caused by mutations in the amyloid β protein precursor (APP), Presenilin 1 or 2, though these causes of AD are relatively uncommon. But those genetic risk factors account for less than 2% of all AD causes, remaining are sporadic AD.Amyloid β protein (Aβ) is one of the abnormally accumulated proteins in AD's brain. Aβ fibril formation and deposition long have been linked to the neuropathogenesis of AD. And abnormal processing of APP and increase in Aβ may play a major role in the pathogenesis of the hereditary forms and also that of sporadic AD.We investigate the relationship between APP, Aβ and cholesterol to find the evidence that cholesterol may play a role in the cleavage of APP. We made APP-overexpressed CHO cells and npc1 defected CHO (nCHO) cells by transfect the wild type, Swedish and Tottori (D678N) type mutated APP. Npc1 is defected in Niemann-Pick disease type C, which has lack in intracellular transport and maintenance of homeostasis of cholesterol. We analyzed intracellular quantity, synthesis and esterification of cholesterol, but excess APP had no effects directly. Then we determined intracellular APP levels and production Aβ in different intracellular cholesterol background using both cells with extracellular stimulation of Aluminum, LDL and oxidative stress.Despite no relationship APP, Aβ and Aluminum, more sensitive against Aluminum in nCHO cells compared normal cells. Exposure of excess LDL induced the cleavage of APP by β-secretase in nCHO cells, which indicated Aβ production. Intracellular APP levels on the oxidative stress were decreased in CHO cells but not affected in nCHO. Fewer lipids in nCHO of membrane in nCHO may prevent the oxidative attack against cell membrane.The disruption of cholesterol homeostasis might accelerate and strengthen the risks in AD.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Watanabe Y, Shimizu Y, Urakami K, Matsushima E, Nakashima K: "Vertical ophthalmoplegia in a demented patient with striato pallidodentate calcification"Psychiatry Clin.Neurosci.. 57・4. 447-450 (2003)
渡边 Y、清水 Y、浦上 K、松岛 E、中岛 K:“伴有纹状体苍白齿状钙化的痴呆患者的垂直眼肌麻痹”精神病学临床.神经科学.. 57・450 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakutani Y, Kowa H, Kusumi M, Nakaso K, Yasui K, Wada-Isoe K, Urakami K, et al.: "The regulatory region polymorphisms of the MTHFR gene are not associated with Alzheimer's disease"Dement.Geriatr.Cogn.Disord.. 17・3. 147-150 (2004)
Wakutani Y、Kowa H、Kusumi M、Nakaso K、Yasui K、Wada-Isoe K、Urakami K 等人:“MTHFR 基因的调控区多态性与阿尔茨海默病无关”Dement.Geriatr.Cogn.Disord .. 17・3. 147-150 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer's disease with spastic paraparesis
患有痉挛性截瘫的早发性阿尔茨海默病患者中发现一种新的早老素 1 突变 (Y154N)
DOI:
--
发表时间:
2004
期刊:
Neuroscience Letters 368
影响因子:
--
作者:
[Hattori H, Sakuma K, Wakutani Y, Wada K, Shimoda M, Urakami K, Kowa H, Nakashima K]
通讯作者:
Nakashima K
浦上克哉, 谷口美也子: "アルツハイマー病に対するその他の治療の試みの現況"老年精神医学雑誌. 14・5. 567-569 (2003)
Katsuya Urakami、Miyako Taniguchi:“阿尔茨海默病其他治疗尝试的现状”《老年精神病学杂志》14・5(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakutani Y, Watanabe K, Adachi Y, Isoe-Wada K, Urakami K, et al.: "Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease"J.Neurol.Neurosurg.Psychiatr.. (in press). (2004)
Wakutani Y、Watanabe K、Adachi Y、Isoe-Wada K、Urakami K 等人:“可能的家族性阿尔茨海默病中的新型淀粉样前体蛋白基因错义突变 (D678N)”J.Neurol.Neurosurg.Psychiatr..(出版中)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Dementia Prevention - Early Detection by Olfactory Function Test and Prevention by Aromatherapy
-
批准号:20K07886
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:URAKAMI Katsuya
-
依托单位:
The analysis of altered glycosylation in Alzheimer's disease
-
批准号:22590933
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:URAKAMI Katsuya
-
依托单位:
Clinical utilization of β-Acl, newly identified Aβ associated protein, as a novel diagnostic marker of Alzheimer's disease.
-
批准号:18590940
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2006
-
负责人:URAKAMI Katsuya
-
依托单位:
Abnormality of free radical scavenging mechanism in skin fibroblasts with dementia of the Alzheimer type
-
批准号:05670558
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:URAKAMI Katsuya
-
依托单位:
Superoxide dismutase 1 in patients with dementia of the Alzheimer type.
-
批准号:02670358
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1990
-
负责人:URAKAMI Katsuya
-
依托单位: